vinpocetine has been researched along with Ache in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alves-Filho, JC; Casagrande, R; Cunha, FQ; Cunha, TM; Pinho-Ribeiro, FA; Ruiz-Miyazawa, KW; Silva, RL; Staurengo-Ferrari, L; Verri, WA; Zarpelon, AC | 1 |
Csillik, B; Knyihár-Csillik, E; Mihály, A | 1 |
Csillik, B; Farkas, I; Knyihár-Csillik, E; Krisztin-Péva, B; Mihály, A | 1 |
3 other study(ies) available for vinpocetine and Ache
Article | Year |
---|---|
Vinpocetine reduces lipopolysaccharide-induced inflammatory pain and neutrophil recruitment in mice by targeting oxidative stress, cytokines and NF-κB.
Topics: Animals; Cytokines; Lipopolysaccharides; Macrophages; Male; Mice; Neutrophils; NF-kappa B; Oxidative Stress; Pain; Peritoneal Cavity; Peroxidase; Vinca Alkaloids | 2015 |
Antinociceptive effect of vinpocetine--a comprehensive survey.
Topics: Acid Phosphatase; Analgesics; Animals; Calcitonin Gene-Related Peptide; Densitometry; Formaldehyde; Male; Nerve Growth Factor; Neuroprotective Agents; Pain; Pain Measurement; Phosphoric Monoester Hydrolases; Rats; Rats, Wistar; Spinal Cord; Substance P; Vinca Alkaloids | 2010 |
Mitigation of nociception via transganglionic degenerative atrophy: possible mechanism of vinpocetine-induced blockade of retrograde axoplasmic transport.
Topics: Analgesics; Animals; Axonal Transport; Disease Models, Animal; Male; Nerve Degeneration; Pain; Pain Measurement; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Spinal Cord; Vinca Alkaloids | 2008 |